ALS LIMITED (ALQ)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALQ - ALS LIMITED

FNArena Sector : Industrial Sector Contractors & Engineers
Year End: March
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 2.92
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

ALS Ltd provides laboratory and testing services across the mining, industrial and life sciences sector. It operates in over 65 countries. Formerly Campbell Brothers Ltd it first listed in 1952 and changed name to ALS in 2012.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$15.48

23 Dec
2024

0.230

OPEN

$15.31

1.51%

HIGH

$15.48

497,109

LOW

$15.20

TARGET
$16.54 6.8% upside
Franking for last dividend paid out: 30%
OTHER COMPANIES IN THE SAME SECTOR
3DA . AVD . BSA . CG1 . CLG . CVL . CWY . CXL . DOW . DUR . EGL . EGN . EVS . FLC . IPG . LBL . MAD . PPK . RWL . SDV . SHA . SND . SSM . VEE . VNT .
FNARENA'S MARKET CONSENSUS FORECASTS
ALQ: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 2.7 63.3 xxx
DPS (cps) xxx 39.2 38.0 xxx
EPS Growth xxx - 95.4% 100.0% xxx
DPS Growth xxx - 1.3% - 3.1% xxx
PE Ratio xxx N/A 24.5 xxx
Dividend Yield xxx N/A 2.5% xxx
Div Pay Ratio(%) xxx 1468.2% 60.0% xxx

Dividend yield today if purchased 3 years ago: 3.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 2.53

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 23/11 - ex-div 19.6c (franking 20%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx2.7
DPS All xxxxxxxxxxxxxxx39.2
Sales/Revenue xxxxxxxxxxxxxxx2,461.6 M
Book Value Per Share xxxxxxxxxxxxxxx244.4
Net Operating Cash Flow xxxxxxxxxxxxxxx359.2 M
Net Profit Margin xxxxxxxxxxxxxxx0.52 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx1.01 %
Return on Invested Capital xxxxxxxxxxxxxxx0.48 %
Return on Assets xxxxxxxxxxxxxxx0.36 %
Return on Equity xxxxxxxxxxxxxxx1.01 %
Return on Total Capital xxxxxxxxxxxxxxx15.86 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx17.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx318 M
Long Term Debt xxxxxxxxxxxxxxx1,554 M
Total Debt xxxxxxxxxxxxxxx1,872 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx300 M
Price To Book Value xxxxxxxxxxxxxxx5.37

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx151.7 M
Capex % of Sales xxxxxxxxxxxxxxx6.16 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,624 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx371 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx46 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

xx/xx/xxxx

1

xxxxxxxxxx xx xxxxxxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

20/11/2024

1

Outperform

$16.25

4.97%

ALS Ltd reported higher-than-forecast net profit in H1, Macquarie notes. Life science margins were better than expected, with environmental generating organic revenue growth of 12% and a lift in earnings margin by 137bps, including acquisition benefits from Lims.

The analyst notes a forex impact of around -$16m in earnings or -$11m at the net profit level due to the strength of the AUD relative to the Canadian dollar and Latin American currencies.

Macquarie increases EPS forecasts by 2.5% for FY25 and 3% for FY26, driven by higher life science margins and a recovery in commodities in 2026/2027. Leverage is at the higher end of management's range post-acquisitions.

The target price rises to $16.25 from $15. No change to the Outperform rating.

FORECAST
Macquarie forecasts a full year FY25 dividend of 38.40 cents and EPS of 64.00 cents.
Macquarie forecasts a full year FY26 dividend of 44.60 cents and EPS of 74.40 cents.

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

xx/xx/xxxx

3

xxxxxxxxx xx xxxxxxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Goldman Sachs

23/09/2024

1

Buy

$14.85

-4.07%

Goldman Sachs observes the 1H25 trading update from ALS Ltd with a -5% decline in expected net profit because of weaker commodities and higher financing costs, via leases and interest expenses.

Life sciences offset some of the weakness including over 10% growth in environmental across all geographies.

The broker cuts EBIT forecasts by -6% in FY25 and -4% in FY26.

Buy rating unchanged. Target price falls -5% to $14.85.

FORECAST
Goldman Sachs forecasts a full year FY25 dividend of 27.00 cents and EPS of 62.00 cents.
Goldman Sachs forecasts a full year FY26 dividend of 40.00 cents and EPS of 68.00 cents.
Access Extra Coverage Research History >

ALQ STOCK CHART

FNArena News on ALQ

1
Rudi’s View: Final Best Buys & Conviction Ideas

Dec 23 2024 - Rudi's View
2
ESG Focus: The Little Big Things – 19-12-2024

Dec 23 2024 - ESG Focus
3
Rudi’s View: Banks, WiseTech, Redox & Integral Diagnostics

Dec 19 2024 - Rudi's View
4
Rudi’s View: Best Buys & Smaller Cap Favourites

Dec 12 2024 - Rudi's View
5
Rudi’s View: In Santa We Trust (?)

Dec 05 2024 - Rudi's View

Latest Industrial Sector Contractors & Engineers News

1
Rising Margins Boost ALS’ Favourable Outlook

Nov 22 2024 - Australia
2
A Golden Era For Engineering Services?

Oct 30 2024 - Feature Stories
3
How the Tides Turn: Water Scarcity And Services In Australia

Oct 14 2024 - ESG Focus
4
Transitory Headwinds For ALS

Sep 30 2024 - Australia
5
Cleanaway’s Efforts Not Wasted

Sep 23 2024 - Australia
6
IPD Group’s Future Remains Electrifying

Sep 06 2024 - Small Caps
7
It’s Electric Under The Southern Cross

Jul 24 2024 - Small Caps
8
Ventia Services: Unique Mix Of Growth & Defence

Jul 09 2024 - Small Caps
9
In The Bin; ASX-Listed Waste Companies

Nov 02 2023 - Australia
10
Treasure Chest: ALS Has A Turn-Around Option

Sep 19 2023 - Treasure Chest